HHS Recommends Rescheduling Cannabis, Surprising an Entire Industry
Co-Author, Cannabis Industry Journal, Sept. 13, 2023
In the most unexpected development to hit the cannabis industry in years, the U.S. Department of Health and Human Services’ (HHS) Secretary Xavier Becerra shared his agency’s recommendation that, based on data and scientific analysis, cannabis, a Schedule I drug under the Controlled Substances Act, should be reclassified as a Schedule III drug. The announcement was made on Wednesday, August 30.
HHS’ conclusion was sent by letter to the Drug Enforcement Administration (DEA), the agency with authority to reclassify how various substances are treated under federal drug laws. The HHS recommendation means that the nation’s top health agency no longer considers cannabis a drug that lacks medical value and carries the high potential for abuse.
Click here to read the full article.
Contributors:
Recent Insights
Read MoreFCC Moves to Address Offshore Call Centers and Foreign Robocalls
Presentation | March 10, 2026What’s Next for Denver’s Sports Facilities and Stadium Development
Presentation | March 09, 2026Equity in Action: Embedding Justice in Land Use Decisions
Article | March 09, 2026Tina Peters clemency? Her sentence was drastically harsher than those of two Democratic lawmakers (Opinion)
Client Alert | March 06, 202630 Races, 11 Open Seats: What to Watch During the 2026 State AG Elections
Presentation | March 06, 2026Public Policy, Legislative Issues and the Upcoming Elections
You have chosen to send an email to Brownstein Hyatt Farber Schreck or one of its lawyers. The sending and receipt of this email and the information in it does not in itself create and attorney-client relationship between us.
If you are not already a client, you should not provide us with information that you wish to have treated as privileged or confidential without first speaking to one of our lawyers.
If you provide information before we confirm that you are a client and that we are willing and able to represent you, we may not be required to treat that information as privileged, confidential, or protected information, and we may be able to represent a party adverse to you and even to use the information you submit to us against you.
I have read this and want to send an email.